| abstract |
A pharmaceutical composition containing O-(5-amino-2-phenylbenzoxazol-7-yl)methyl-3,5-dichloro-L-tyrosine or a pharmaceutically acceptable salt thereof for use in the treatment of a disease in a subject, for example, an allergic disease, autoimmune disease, or inflammatory disease, wherein the pharmaceutical composition is administered to the subject having a non-rapid (slow and/or intermediate) NAT2 gene. |